Oct 28HHS draft policy lets licensed pharmacies compound six peptides, including BPC-157. What changed and what did not.
Skip to content
PeptideAgent

How much does CJC-1295 cost?

By the PeptideAgent Editorial Team. Editorially reviewed, not clinically reviewed.  Last verified

The short answer

Not covered; there is no approved or lawfully compounded product to cover.

Regulatory: Nomination withdrawnVerified: Verified Sep 23, 2026
With insurance
Not published
Compounded pharmacy
Not published

What each price includes, with sources

What does CJC-1295 cost in each channel?

Prices in US dollars at the verification date. Ranges are published list or program prices where a primary source exists; notes say when a figure is a typical market range instead.

CJC-1295 price by purchase channel
ChannelPrice (USD)Notes
With insuranceNot publishedNot covered. Medicare Part D and commercial pharmacy benefits cover FDA approved drugs for accepted indications; compounded or unapproved peptides are paid in cash. [3]
Compounded pharmacyNot publishedNo lawful compounded price. CJC-1295 was placed on 503A Category 2 in September 2023, its nomination was later withdrawn, and it is not on the bulks list or a component of an approved drug. Products sold as research chemicals for human use are unapproved drugs and are unverified for identity or purity. [1] [2] [4]

Why is there no price for CJC-1295?

FDA has found compounding pharmacies offering CJC-1295 anyway. [5] [6]

Clinics and telehealth programs may quote you a cash price for CJC-1295. PeptideAgent lists none, for two reasons. There is no CJC-1295 product to price: none is FDA approved, and a pharmacy has no federal basis to compound it. [1] [2] A quoted price is for a product FDA has not checked for safety, effectiveness, or quality, so it is not the price of a reviewed drug. [7]

If you're going ahead anyway: the checklist on the CJC-1295 page. These steps lower some risks. They do not make the product safe, and they do not give a pharmacy a federal basis to compound CJC-1295, with or without a prescription. [2]

  • Check the pharmacy's license
  • What a legitimate prescription and consult look like
  • Why this is safer than a research-use-only product
  • Questions to ask the pharmacy, the telehealth company, the prescriber, and anyone offering it

What is the list price of CJC-1295?

There is no list price and no licensed channel. Products sold as CJC-1295 with or without DAC are not approved anywhere, and research chemical products sold for human use are unapproved drugs.

Does insurance cover CJC-1295?

Not covered; there is no approved or lawfully compounded product to cover.

What changes the price?

  • Absence of any lawful compounding basis since the 2023 Category 2 placement and later withdrawal

Frequently asked questions

How much does CJC-1295 cost without insurance?

No lawful compounded price. CJC-1295 was placed on 503A Category 2 in September 2023, its nomination was later withdrawn, and it is not on the bulks list or a component of an approved drug. Products sold as research chemicals for human use are unapproved drugs and are unverified for identity or purity. [1] [2] [4]

Does insurance cover CJC-1295?

Not covered; there is no approved or lawfully compounded product to cover. [3]

What is the list price of CJC-1295?

There is no list price and no licensed channel. Products sold as CJC-1295 with or without DAC are not approved anywhere, and research chemical products sold for human use are unapproved drugs.

From the blog

Sources

  1. [1]FDA: Certain bulk drug substances for use in compounding may present significant safety risks (Category 2 list and withdrawn nominations, content current as of April 22, 2026)FDA
  2. [2]FDA: Bulk drug substances used in compounding under section 503A of the FD&C Act (links to the Category 1, 2, and 3 lists and the bulks list)FDA
  3. [3]Medicare.gov: prescription drug coverage (Part D and outpatient drugs)
  4. [4]FDA warning letter 735063, August 24, 2026, to an online seller of research-use-only peptides: products labeled research use only were unapproved new drugs (FDA warning letters database)FDA, 2026
  5. [5]FDA warning letter 594743, April 1, 2020, to a state-licensed 503A compounding pharmacy (FDA warning letters database)FDA, 2020
  6. [6]FDA briefing document, Pharmacy Compounding Advisory Committee, October 29, 2024 (includes ipamorelin)FDA, 2024
  7. [7]FDA: Compounding and the FDA, questions and answersFDA